Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Medicine

- PMLiVE

Ipsen’s tumour treatment receives MHRA marketing authorisation

This is the first approval in the UK for previously treated advanced neuroendocrine tumours

- PMLiVE

New National Commission launched to strengthen AI regulation

The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance

- PMLiVE

Will data and AI prove to be the game-changer that transforms launch excellence?

Investing in data analytics and AI tools can lead to smarter clinical trials and faster, more informed decisions

- PMLiVE

New survey: Europeans seek better health equity in breast cancer awareness

‘More than 558,000 new breast cancer cases are diagnosed annually and the disease claims around 145,000 lives each year’

- PMLiVE

Novartis announces new data supporting MS therapy Kesimpta

The latest trial results reinforce the drug's long-term efficacy and safety profile

- PMLiVE

EMA reaffirms guidance on paracetamol use during pregnancy

The guidance follows recent US comments about a possible link to autism

- PMLiVE

Lilly to spend $6.5bn on second of four US manufacturing facilities

The new facility in Texas is expected to create 4,615 manufacturing and construction jobs

- PMLiVE

SAY Communications teams up with Overcoming MS, a multiple sclerosis charity

The MS charity is this year’s recipient of the company’s pro bono programme

MK-Gavin-Inizio

Inizio strengthens executive team with new leadership appointments

Inizio has appointed Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer, strengthening its executive leadership to drive innovation, digital transformation, and Intelligent Commercialization™...

Inizio

PM360AwardsInizio

Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards

Inizio has been named a finalist in six categories at the 2025 PM360 Trailblazer Awards, recognizing its teams’ excellence in AI, data analytics, education, patient engagement, and industry partnership across...

Inizio

Voices-of-Oncology-Inizio

Inizio leaders featured in Forbes’ ‘Voices of Oncology’ to drive innovation in cancer care

Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care through advanced data analytics, cross-sector collaboration, and real-world impact for patients.

Inizio

- PMLiVE

Biogen expands portfolio in deal with Alcyone Therapeutics

The agreement gives Biogen full rights to a potential therapy for patients with neurological disorders

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links